BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 19635298)

  • 1. Pediatric melanoma: a single-institution experience of 150 patients.
    Aldrink JH; Selim MA; Diesen DL; Johnson J; Pruitt SK; Tyler DS; Seigler HF
    J Pediatr Surg; 2009 Aug; 44(8):1514-21. PubMed ID: 19635298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting.
    Tan KB; Moncrieff M; Thompson JF; McCarthy SW; Shaw HM; Quinn MJ; Li LX; Crotty KA; Stretch JR; Scolyer RA
    Am J Surg Pathol; 2007 Dec; 31(12):1902-12. PubMed ID: 18043047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
    Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
    Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing time between biopsy and definitive surgery for malignant melanoma: do they impact clinical outcome?
    Carpenter S; Pockaj B; Dueck A; Gray R; Kurtz D; Sekulic A; Casey W
    Am J Surg; 2008 Dec; 196(6):834-42; discussion 842-3. PubMed ID: 19095097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.
    Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M
    Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma.
    Posther KE; Selim MA; Mosca PJ; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg Oncol; 2006 May; 13(5):728-39. PubMed ID: 16538415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
    Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
    Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An increased number of sentinel lymph nodes is associated with advanced Breslow depth and lymphovascular invasion in patients with primary melanoma.
    Schmidt CR; Panageas KS; Coit DG; Patel A; Brady MS
    Ann Surg Oncol; 2009 Apr; 16(4):948-52. PubMed ID: 19194758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk surgically resected pediatric melanoma and adjuvant interferon therapy.
    Chao MM; Schwartz JL; Wechsler DS; Thornburg CD; Griffith KA; Williams JA
    Pediatr Blood Cancer; 2005 May; 44(5):441-8. PubMed ID: 15468307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution.
    Ferrari A; Bono A; Baldi M; Collini P; Casanova M; Pennacchioli E; Terenziani M; Marcon I; Santinami M; Bartoli C
    Pediatrics; 2005 Mar; 115(3):649-54. PubMed ID: 15741367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic study of recurrent Clark level II melanomas.
    Glass LF; Guffey JM; Schroer KR; Reintgen D
    Semin Surg Oncol; 1993; 9(3):202-7. PubMed ID: 8516604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study.
    Swetter SM; Soon S; Harrington CR; Chen SC
    Arch Dermatol; 2007 Jan; 143(1):30-6. PubMed ID: 17224539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases.
    Chen JY; Hruby G; Scolyer RA; Murali R; Hong A; Fitzgerald P; Pham TT; Quinn MJ; Thompson JF
    Cancer; 2008 Nov; 113(10):2770-8. PubMed ID: 18823042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
    Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
    Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.